Status:
TERMINATED
Non-invasive Detection of Male Infertility With FDG-PET/MRI (Spectroscopy and DWI)
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Fertility Disorders
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The aim of the study is to examine the value of the new MRI techniques (spectroscopy and DWI), and FDG-PET in prognostication of male infertility.
Detailed Description
The diagnostic workup of male infertility includes medical history, physical examination and semen analysis. In severe cases further workup includes testicular ultrasound, analysis of genes and hormon...
Eligibility Criteria
Inclusion
- 18-40 year old males referred to fertility treatment at Rigshospitalet, Denmark. 10 men with a normal sperm count and 10 men with no sperm cells in the ejaculate will be included. The patients shall be able to understand the patient information and be able to give informed consent.
Exclusion
- Severe claustrophobia Age: less than 18 or above 40 Severe obesity (\> 140 kg) Pacemaker or other electronic in-operated devices Non-MR compatible metallic devices Malignant testicular tumors suspected at clinical examination or ultrasound Infectious testicular diseases
Key Trial Info
Start Date :
August 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 7 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03250195
Start Date
August 7 2017
End Date
August 7 2021
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Østerbro, Denmark, 2100